HealthStream
HSTM
158 hedge funds and large institutions have $458M invested in HealthStream in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 73 reducing their positions, and 13 closing their positions.
46% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 13
4% more funds holding
Funds holding: 152 → 158 (+6)
0.13% less ownership
Funds ownership: 70.65% → 70.52% (-0.13%)
2% less capital invested
Capital invested by funds: $469M → $458M (-$11M)
40% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 73
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| 1 |
Millennium Management
New York
|
+$4.24M |
| 2 |
First Eagle Investment Management
New York
|
+$1.5M |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$1.38M |
| 4 |
Morgan Stanley
New York
|
+$1.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
HSTM Hedge Fund Activity: Q3 2022 in Review
158 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in HealthStream (HSTM) for Q3 2022, worth a combined $458M — down 2.3% from $469M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new HSTM positions and 13 closed out — a net gain of 6 holders — while 44 added to existing stakes and 73 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.24M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $2.71M.
- 158 institutional investors held HealthStream (HSTM) as of Q3 2022, up from 152 in Q2 2022.
- Funds reported $458M of HealthStream stock for Q3 2022, down 2.3% quarter-over-quarter.
- 19 funds opened new HealthStream positions in Q3 2022 and 13 closed out, a net change of +6 holders.
- The largest HealthStream buyer in Q3 2022 was Millennium Management, an estimated $4.24M added.
- The largest HealthStream seller in Q3 2022 was Brown Brothers Harriman & Co, an estimated $2.71M sold.
Based on aggregated 13F filings for Q3 2022.